MedTrace Logo

Long Term Outcome in ICU Treated COVID-19: Return to Work

NCT05054608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13537

Last updated 2022-12-05

No results posted yet for this study

Summary

Return to work (not being on sick leave) within one year after intensive care unit (ICU) admission with Coronavirus disease 2019 (COVID-19) will be assessed. Risk and risk factors for not having returned to work will be compared to patients admitted to hospital and general population controls.

The ICU population comprises all Swedish ICU patients with COVID-19 with at least one year of follow up. The hospital admitted cohort comprises four hospital admitted patients with COVID-19 per ICU patient, matched on age, legal gender and region. The general population controls are matched to the ICU patients in a one to four fashion on age, legal gender and region.

ICU patients are identified in the Swedish intensive care registry. The hospital admitted patients are identified in the national patient registry and the population controls are identified in the population registry. Data on socioeconomics and income are provided by the Statistics Sweden. Data on comorbidity, medications and death are provided from the National board of health and welfare. Finally, data on sick leave are provided from the Swedish Social Insurance Agency.

Conditions

  • Covid19

Interventions

OTHER

No intervention

Observational study. No intervention.

Sponsors & Collaborators

  • Dalarna County Council, Sweden

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Miklos Lipcsey, Professor · Uppsala University

Eligibility

Min Age
18 Years
Max Age
63 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2021-11-15
Completion
2021-11-15

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05054608 on ClinicalTrials.gov